Cheap Heart Drugs Cut Obesity Health Risks Over 25 Years

For a quarter century, something remarkable has been happening with heart health. People over 40 with obesity are closing the gap on cardiovascular risk factors, and inexpensive medications deserve much of the credit.

A major study tracking 1 million adults across seven countries found that older people with obesity now have blood pressure and cholesterol levels matching or even better than peers with normal weight. The research, published in the Lancet, followed participants from 1990 to 2024 across England, the United States, Japan, South Korea, Taiwan, Thailand, and Finland.

The difference is striking among 60 and 70-year-olds. Blood pressure readings and unhealthy cholesterol levels fell more sharply in people with obesity than in those with normal body mass index during the study period.

What changed? Generic blood pressure pills and statins became widely used by middle-aged people with obesity. These medications cost around $100 per year in the United States, making them accessible prevention tools.

Among the oldest adults studied, 70% to 72% with overweight or obesity were taking these heart drugs, compared to just 40% to 48% of people with normal weight. The medications appear to be neutralizing some of the cardiovascular dangers that obesity traditionally carried.

"The findings suggest that some cardiovascular consequences of obesity are increasingly being attenuated through medical management," wrote Yale University researcher Yuan Lu in a commentary on the study.

But there's a worrying gap. Adults under 40 saw no such improvement, regardless of their weight. Young people rarely receive cholesterol or blood pressure screening, meaning they miss out on early prevention.

The Bright Side

This research proves that affordable interventions can make a massive difference in public health. For decades, doctors have prescribed generic statins and blood pressure medications to millions of patients. That quiet, consistent prevention work is paying off in measurable ways.

The study doesn't mean obesity has become harmless. People with obesity still face higher risks for diabetes, certain cancers, kidney disease, and joint problems. But it shows that addressing specific risk factors through medication can level the playing field for heart health.

"This is good news," said Dan Jones, former president of the American Heart Association. The challenge now is extending these benefits to younger adults through better screening and prevention.

The research also highlights that health doesn't follow simple rules. Some thin people have dangerously high cholesterol or blood pressure due to genetics or other conditions. Meanwhile, people with obesity taking the right medications can have excellent cardiovascular numbers.

What matters most is treating the risk factors we can measure and control. That approach, sustained over 25 years with affordable drugs, has quietly transformed heart health for millions.

Simple solutions, applied consistently, can change the trajectory of an entire generation's health.